Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • yl01
    Member
    • Aug 2012
    • 25

    #1

    Running cufflinks without the -G or the -g option

    Hi,

    I am analyzing an RNA-seq dataset using tophat and cufflinks. Mostly I followed the procedures described in the Nature Protocol paper (http://www.ncbi.nlm.nih.gov/pubmed/22383036). According to the paper, in the cufflinks step to assemble transcript for each sample, the cufflinks was run without either the -G or the -g option. Because I wannted to find novel transcript isoforms, I shouldn't use -G (no novel transcripts assembly). I am just wondering if I should use the option -g (does an RABT assembly) or not. Actually the question is if cufflinks does novel transcript assembly if I don't use either the -G or the -g option.

    Thanks in advance!
  • 413fei
    Junior Member
    • May 2013
    • 5

    #2
    I have the same question. Can anyone answer this question?

    Comment

    • WhatsOEver
      Senior Member
      • Apr 2012
      • 215

      #3
      Originally posted by yl01 View Post
      Actually the question is if cufflinks does novel transcript assembly if I don't use either the -G or the -g option.
      Sorry if I misunderstand the question, but if you don't provide an annotation file, how should cufflinks decide whether a prediction is novel or not?
      However, you can still compare your assembled transcripts against an existing annotation afterwards using cuffcompare with the the -r parameter.

      Comment

      • Sheree Yau
        Junior Member
        • Mar 2014
        • 6

        #4
        I'm also just starting to use cufflinks following the Nature Protocols paper. In the paper they provide a genes.gtf file at the cuffmerge stage, which as WhatsOEver says, is implementing cuffcompare to compare the assembled transcripts to an existing annotation. This way you can see which are novel transcripts and which were the same as predicted.

        Related to this query.
        My understanding from the manual was that when running cufflinks with -g genes.gtf "Output will include all reference transcripts as well as any novel genes and isoforms that are assembled" so -g should not stop isoform detection. However, in the Nature Protocol, -g genes.gtf is not used in the cufflinks stage. I wonder how including the annotation might affect isoform detection, for example, will this reduce sensitivity? or will this reduce false positives?

        I have run cufflinks with the annotation and from my cuffdiff output, I seem to have some isoforms detected, but they are not significantly different between samples. I suspect it depends on sequencing depth, the organism and other factors but I'd be interested to hear the advantages or disadvantages of including the annotation in the cufflinks assembly stage too.

        Comment

        • yl01
          Member
          • Aug 2012
          • 25

          #5
          Thanks for the answers. I read a little more and seem to have the answer to my question. Without both the -G and -g options when running cufflinks, cufflinks will run using the riginal cufflinks assembler, which is able to detect novel genes and isoforms. Using the -g option, the RABT assembler will be used, which is also able to detect novel genes and isoforms. The RABT method is described in paper (http://www.ncbi.nlm.nih.gov/pubmed/21697122) in more detail, including comparing to the original cufflinks assembler. Still not sure which one is better though. Practically the running by using RABT takes significantly longer.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 11:13 AM
          0 responses
          16 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, Yesterday, 10:48 AM
          0 responses
          15 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          35 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          42 views
          0 reactions
          Last Post SEQadmin2  
          Working...